Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 220, No. 4, 2006   

Free Abstract     Article (Fulltext)     Article (PDF 232 KB)     

Original Paper

Experimental Model for Proliferative Vitreoretinopathy by Intravitreal Dispase: Limited by Zonulolysis and Cataract
Martina T. Kralingera, b, Gerhard F. Kieselbacha, b, Monika Voigtb, c, Brandy Haydenb, Eleut Hernandezb, Viviana Fernandezb, Jean-Marie Parelb, d, e

aDepartment of Ophthalmology, Innsbruck Medical University, Innsbruck, Austria;
bOphthalmic Biophysics Center, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Fla., USA;
cOphthalmic Clinic of Virchow/Charité Hospital, Humboldt University of Berlin, Berlin, Germany;
dCHU Sart-Tilman, Department of Ophthalmology, University of Liège, Liège, Belgium;
eUniversity of Paris, Hopital de l'Hotel-Dieu, Paris, France

Address of Corresponding Author

Ophthalmologica 2006;220:211-216 (DOI: 10.1159/000093073)


 goto top of page Key Words

  • Dispase
  • Experimental model
  • Intravitreal injection
  • Proliferative vitreoretinopathy
  • Cataract
  • Zonulolysis

 goto top of page Abstract

Background: The intravitreal injection of dispase has been shown to be a valuable method for induction of experimental PVR. The goal of the present study was to gain additional information about potential side effects associated with this method. Methods: Twenty-one pigmented rabbits received a single injection of dispase under topical anesthesia to one eye only, contralateral eyes served as untreated control. The animals were injected with doses from 0.045 to 0.065 units of dispase: 8 animals received 0.045 units, 9 animals 0.055 units and 4 animals 0.065 units. Results: Proliferative vitreoretinopathy occurred in 81% of the treated eyes. In 90% cataract formation was observed. Lens luxation was present in 47.3% of the cataract eyes. Conclusion: Intravitreal injection of dispase resulted in the reproducible induction of PVR in addition to cataract formation and lens luxation. Whether these effects may all be associated with a toxic reaction or whether the proliferative changes are solely triggered by endogenous reactions similar to the pathomechanism of human PVR and whether the cataract formation and the lens luxation may be avoided by changing the method of injection require further investigation.

Copyright © 2006 S. Karger AG, Basel


 goto top of page Author Contacts

Prof. Dr. Martina Kralinger
Universitätsklinik für Augenheilkunde und Optometrie
Medizin Universität Innsbruck, Anichstrasse 35
AT-6020 Innsbruck (Austria)
Tel. +43 512 504 24184, Fax +43 512 504 23740, E-Mail martina.kralinger@uibk.ac.at


 goto top of page Article Information

Received: June 4, 2004
Accepted after revision: August 29, 2005
Number of Print Pages : 6
Number of Figures : 7, Number of Tables : 1, Number of References : 28

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 16785750)
Download Citation




For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.





copyright  © 2009 S. Karger AG, Basel